 |
Ablynx, Ghent, Belgium |
|
 |
Amgen, Thousand Oaks and Seattle, USA |
|
 |
AstraZeneca, Södertälje and Mölndal, Sweden and Charnwood, UK |
|
 |
Biogen Idec, Cambridge, USA |
|
 |
Bristol-Myers Squibb Company, Princeton, USA |
|
 |
GE Healthcare Bio-Sciences, Uppsala, Sweden |
|
 |
GlaxoSmithKline, RTP, USA and Stevenage, UK |
|
 |
Huntingdon Life Sciences, Huntingdon, UK |
|
 |
ICON, Manchester and Oxford, UK |
|
 |
MedImmune, Gaithersburg, Hayward and Mountain View, USA and Cambridge, UK |
|
 |
Merck, Westpoint and Rahway, USA |
|
 |
MerckSerono, Fenil-sur-Corsier, Switzerland and Ivrea, Italy |
|
 |
National Research Centre for the Working Environment (AMI), Copenhagen, Denmark |
|
 |
National Veterinary Institute, Uppsala, Sweden |
|
 |
Novartis Vaccines, Siena, Italy |
|
 |
NovImmune, Geneva, Switzerland |
|
 |
Novo Nordisk, Målöv, Denmark |
|
 |
Pfizer, Sandwich, UK and Groton, USA |
|
 |
Predictive Physiology & Medicine, Inc., Bloomington, USA |
|
 |
ProBioGen, Berlin, Germany |
|
 |
Quotient Bioresearch (formerly HFL), Fordham, UK |
|
 |
Recipharm,
Södertälje, Sweden |
|
 |
Rentschler Biotechnologie, Laupheim, Germany |
|
 |
Roche, Penzberg, Germany |
|
 |
Royal Institute of Technology, Stockholm, Sweden |
|
 |
Rudbeck Laboratory,
Uppsala, Sweden |
|
 |
Syrinx Bioanalytics, Turku, Finland |
|
 |
Thrombogenics,
Heverlee, Belgium |
|
 |
York Bioanalytical Solutions, York, UK |
|